A Phase I Study of a Combination of High Selenium Brassica Juncea With Irinotecan and Capecitabine.
Phase of Trial: Phase I
Latest Information Update: 10 Sep 2012
At a glance
- Drugs Capecitabine (Primary) ; Selenium (Primary) ; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClincialTrials.gov.
- 13 Jun 2012 Planned End Date changed from 1 Oct 2012 to 1 Apr 2015 as reported by ClincialTrials.gov.
- 13 Sep 2011 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.